Patent · US Active

Antibodies that bind human CD27 and uses thereof

US11180566B2 · kind B2 · utility

1Cited by

14References

7Claims

0Family size

Assignee

Celldex Therapeutics, Inc. · US

Inventors

Tibor Keler · Ottsville, US
Henry C. Marsh, Jr. · Reading, US
Lizhen He · Allentown, US
Laura A. VITALE · Doylestown, US
Lawrence J. Thomas · Easton, US

Key dates

Filing date	Jul 2, 2015
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Nov 8, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Isolated monoclonal antibodies which bind to human CD27 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.